Delivery Order SPE2DB22D1202-SPE2DB25FVFS2
- Not listed
- The Defense Logistics Agency awarded a $1,533.60 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of 500 capsules of Omeprazole DR 40 mg. This is a non-set-aside contract with an ultimate completion date of July 28, 2025, and represents a delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The work will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Omeprazole DR 40 mg capsules (500-count units) on July 23, 2025, with a contract ceiling value of $1,193.52. This firm fixed-price delivery order represents a non-competitive set-aside, issued under the company's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of performance is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Omeprazole DR 40 mg capsules (90-count unit) on July 25, 2025, with a ceiling value of $1,083.09 and an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as...
- The Defense Logistics Agency awarded a delivery order valued at $1,256.67 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Omeprazole DR 20 mg capsules (1,000 units). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 6, 2025, to be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this...
- The Defense Logistics Agency awarded a delivery order valued at $11,597.84 to AmerisourceBergen Drug Corp for the supply of Omeprazole DR 40 mg capsules (1,000 units) on August 14, 2025. This contract is a firm fixed price delivery order with an ultimate completion date of August 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation, reflecting the vendor's demonstrated...
- The Defense Logistics Agency (DLA) awarded a $3,018.32 delivery order to AmerisourceBergen Drug Corp for the supply of 1,000 omeprazole DR 40 mg capsules, with an ultimate completion date of August 26, 2025. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The omeprazole supply supports federal medical procurement needs for military and veteran healthcare...
- This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 capsules of Omeprazole DR 20 mg, a common prescription medication. The contract has a ceiling value of $1,966.84 and a performance period extending through June 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4,564,109,613 units of Omeprazole DR 40 mg capsules. The award, valued at $1,014.51, has a period of performance through March 29, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp to provide a comprehensive range of pharmaceutical products and...
- The Defense Logistics Agency awarded a $23,515.96 delivery order to AmerisourceBergen Drug Corp for 100 mg/ml omeprazole (OMVOH) on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be performed at...
- This is a $1,646.85 delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) on April 14, 2025. The order is for 4,567,908,457 units of 40 mg Omeprazole DR capsules. The contract has an ultimate completion date of April 15, 2025 and is a firm fixed price contract. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a range of pharmaceutical...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVFS2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Omeprazole DR 20 mg capsules (1,000 count) at a firm fixed price of $1,468.32, with an ultimate completion date of July 28, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order supports the Defense Logistics Agency's Medical Supply Chain operations, which provide pharmaceutical and medical commodities to the Department of Defense and affiliated healthcare systems. Omeprazole is a proton pump inhibitor commonly used to treat gastric acid-related conditions and is a standard pharmaceutical in military medical supply inventories. AmerisourceBergen, one of the nation's largest pharmaceutical distributors, maintains comprehensive federal contracting capabilities across multiple therapeutic domains and has demonstrated consistent competitiveness in DLA pharmaceutical procurement through numerous delivery orders spanning a broad range of medical products and price points.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 7/25/25 |